» Articles » PMID: 37215417

Appraisal of Gastric Stump Carcinoma and Current State of Affairs

Overview
Specialty General Medicine
Date 2023 May 22
PMID 37215417
Authors
Affiliations
Soon will be listed here.
Abstract

Gastric stump carcinoma, also known as remnant gastric carcinoma, is a malignancy arising in the remnant stomach following gastrectomy for a benign or malignant condition. Enterogastric reflux and preexisting risk factors in a patient with gastric cancer are the major contributors to the development of gastric stump carcinoma. The occurrence of gastric stump carcinoma is time-dependent and seen earlier in patients operated on for malignant rather than benign diseases. The tumor location is predominantly at the anastomotic site towards the stomach. However, it can occur anywhere in the remnant stomach. The pattern of lymph node involvement and the type of surgery required is distinctly different compared to primary gastric cancer. Gastric stump carcinoma is traditionally considered a malignancy with a dismal outcome. However, recent advances in diagnostic and therapeutic strategies have improved outcomes. Recent advances in molecular profiling of gastric stump carcinoma have identified distinct molecular subtypes, thereby providing novel therapeutic targets. Also, reports of gastric stump carcinoma following pancreatoduodenectomy and bariatric surgery highlight the need for more research to standardize the diagnosis, staging, and treatment of these tumors. The present review aims to provide an overview of gastric stump carcinoma highlighting the differences in clinicopathological profile and management compared to primary gastric carcinoma.

Citing Articles

Survival outcome and prognostic factors of remnant gastric cancer: a propensity score-matched analysis.

Yan S, Shao Q, Peng W, Cheng M, Liu T, Sheng M J Gastrointest Oncol. 2024; 15(3):908-920.

PMID: 38989409 PMC: 11231863. DOI: 10.21037/jgo-24-58.


Identification of prognostic signatures in remnant gastric cancer through an interpretable risk model based on machine learning: a multicenter cohort study.

Zhan Z, Chen B, Cheng H, Xu S, Huang C, Zhou S BMC Cancer. 2024; 24(1):547.

PMID: 38689252 PMC: 11062017. DOI: 10.1186/s12885-024-12303-9.


A Case Report and Literature Review of Gastric Stump Carcinoma: An Uncommon Entity Following the Billroth II Procedure.

Ansari N, Munairji M, Melki G, Baddoura W Cureus. 2024; 16(1):e52354.

PMID: 38361700 PMC: 10867706. DOI: 10.7759/cureus.52354.


Incidence and risk of remnant gastric cancer after gastrectomy for gastric cancer: a population-based study from the SEER database.

Yan S, Cheng M, Peng W, Liu T, Zhang J, Sheng M BMC Gastroenterol. 2024; 24(1):35.

PMID: 38229048 PMC: 10790470. DOI: 10.1186/s12876-024-03133-x.

References
1.
Di Leo A, Pedrazzani C, Bencivenga M, Coniglio A, Rosa F, Morgani P . Gastric stump cancer after distal gastrectomy for benign disease: clinicopathological features and surgical outcomes. Ann Surg Oncol. 2014; 21(8):2594-600. DOI: 10.1245/s10434-014-3633-6. View

2.
Otsuka R, Hayashi H, Sakata H, Uesato M, Hayano K, Murakami K . Short-term clinical outcomes of laparoscopic gastrectomy for remnant gastric cancer: A single-institution experience and systematic review of the literature. Ann Gastroenterol Surg. 2019; 3(2):181-186. PMC: 6422809. DOI: 10.1002/ags3.12221. View

3.
Dunn L, Shenfine J, Griffin S . Columnar metaplasia in the esophageal remnant after esophagectomy: a systematic review. Dis Esophagus. 2013; 28(1):32-41. DOI: 10.1111/dote.12129. View

4.
PODZIMEK A, Valenta J, Novak V, FESSL V, Klecka J, Opatrny K . [Experience with renal transplantation (author's transl)]. Cas Lek Cesk. 1975; 114(36):1115-21. View

5.
Nakachi A, Miyazato H, Shimoji H, Hiroyasu S, Isa T, Shiraishi M . Microsatellite instability in patients with gastric remnant cancer. Gastric Cancer. 2002; 2(4):210-214. DOI: 10.1007/s101200050065. View